Product Program year 2022 Source: CMS Open Payments

FACS

Device Cell Analysis

PDI 00382903420650

Open in the dashboard

General payments

$4,198

33 payments

Research payments

$0

0 payments

Through program year 2022, $4,198 in general payments and $0 in research payments were reported against FACS (Cell Analysis).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

1 row
Year Kind Amount Payments
2022 General $4,198 33

Breakdown

Who paid General payments · program year 2022
  1. Becton, Dickinson and Company $4,198 33 payments
Top recipients General payments · program year 2022
  1. Rodolfo Munera Infectious Disease · Clifton, NJ $155 4% · 1 payment
  2. Ripple Doshi Cardiovascular Disease · Harvey, IL $155 4% · 1 payment
  3. Qizhi Xie Nephrology · Bridgeville, PA $155 4% · 1 payment
  4. Alireza Mirmiran Radiation Oncology · Omaha, NE $155 4% · 1 payment
  5. Andy Fine Internal Medicine · Littleton, CO $155 4% · 1 payment

The top 5 of 33 recipients; each share is of general payments naming this product in 2022.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2022
  1. Internal Medicine $1,209 30% · 9 practitioners
  2. Emergency Medicine $775 19% · 7 practitioners
  3. Nephrology Internal Medicine $620 15% · 4 practitioners
  4. Cardiovascular Disease Internal Medicine $372 9% · 3 practitioners
  5. Hospitalist $217 5% · 2 practitioners

The top 5 of 12 specialties; each share is of general payments naming this product to practitioners with a specialty in 2022. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2022
  1. Wisconsin $527 13% · 4 recipients
  2. New Jersey $373 9% · 3 recipients
  3. California $372 9% · 3 recipients
  4. Pennsylvania $310 7% · 2 recipients
  5. Florida $310 7% · 3 recipients

The top 5 of 20 states; each share is of general payments naming this product in 2022 where a state was reported.

The top 25 states, free in the app

33 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2022

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record